Precision Oncology in HER2 (ERBB2) Mutation and Guideline-Directed Targeted Therapies
Explore the biology, diagnosis, and management of HER2 (ERBB2)-mutant NSCLC, including molecular characteristics, prognostic implications, targeted therapies, clinical trial evidence, guideline-directed care, and treatment-related toxicities.